Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
, , -
To prospectively test the ability of this model to design new peptides with specific activity, we used a simple optimization strategy to design 15 peptides, five in each of three different activity profiles: selective potency at GCGR, selective potency at GLP-1R or high-potency at both receptors
doi: 10.14348/molcells.2020.2329 24 CoelhoC.SouzaA
After reconstitution, the vial goes straight into the refrigerator
(3) Clinical Validation: Large-scale, well-designed clinical trials are urgently needed to evaluate the safety and efficacy of ferroptosis-targeting strategies (e.g., deferiprone, novel inhibitors) in COPD patients, ideally using biomarker-driven patient selection (e.g., based on MDA, 4-HNE, or GPX4 activity levels)
